ClinicalTrials.gg
Not yet recruitingNCT07372105Periosmile1Updated Jan 28, 2026

Validation of the French Version of the SERQoL Questionnaire

An observational study in Smile and Smile Esthetics, sponsored by Assistance Publique - Hôpitaux de Paris. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-28.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

This observational study aims to validate the French version of the Smile Esthetics-Related Quality of Life (SERQoL) questionnaire in adult patients recruited in two APH-HP dental departments. The study evaluates internal consistency, test-retest reliability, and construct validity of the questionnary. A total of 120 patients will be recruited from dental departments at two AP-HP hospitals.

Read the detailed description

This psychometric validation study involves adult patients receiving their first consultation at AP-HP dental services. The SERQoL questionnaire will be completed twice (at baseline and after 15 days). Internal consistency (Cronbach's alpha), test-retest reliability (intraclass or Pearson correlation), and factor structure (confirmatory factor analysis) will be analyzed. No clinical intervention is involved, and participation will not alter standard care.

02

Conditions studied

  • Smile
  • Smile Esthetics

Keywords

  • smile esthetics
  • life quality
  • SERQoL
  • psychometric validation
  • patient-reported outcomes
03

In context

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,598 studies on the registry; 1,038 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients attending a first consultation in the dental department of Rothschild or Charles Foix hospitals (AP-HP). Participants must speak and understand French and have not opposed participation.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Patients attending their first periodontal consultation at the oral medicine departments of Rothschild Hospital (AP-HP) or Charles Foix Hospital (AP-HP)
  • Patients who speak and understand French well enough to read and understand the study information sheet.
  • Patients who are informed and do not object to participating in the study

Exclusion criteria

Exclusion Criteria:

  • Patients under guardianship or curatorship
  • Patients who are completely edentulous, whether the edentulism is compensated or not

    • Patients with multiple dental agenesis (more than 6 teeth), amelogenesis, or syndromic or non-syndromic dentinogenesis imperfecta
    • Patients with psychiatric illnesses that may impact body image, such as patients with anorexia-bulimia or body dysmorphic disorder.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
120 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Measure of the internal consistency by the Cronbach's alpha

    Measure of the questionnaire internal consistency by the Cronbach's alpha

    Time frame: Day 15

  2. Measure of the test-retest reliability by the intraclass or Pearson correlation

    Measure of the questionnaire test-retest reliability by the intraclass or Pearson correlation

    Time frame: Day 15

  3. Measure of the factor structure by the confirmatory factor analysis.

    Measure of the questionnaire factor structure by the confirmatory factor analysis

    Time frame: Day 15

Secondary outcomes

  1. Average score measure by gender

    Average questionnaire score measure by gender

    Time frame: Day 0

  2. Average score measure by age

    Average questionnaire score measure by gender

    Time frame: Day 0

  3. Average score measure according to periodontal health status

    Average questionnaire score measure according to periodontal health status

    Time frame: Day 0

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2026; primary completion for Jul 2026, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 20, 2026
First posted
Jan 28, 2026
StartEst.
Jan 2026
Primary completionEst.
Jul 2026
CompletionEst.
Jul 2026
Last update
Jan 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07372105
Responsible party
Sponsor
First posted
Jan 28, 2026
Start date
Jan 2026 (estimated)
Primary completion
Jul 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Jan 28, 2026

Study contacts

Bruno TAVERNIER, PU-PH
Contact
bruno.tavernier@aphp.fr
+33 (0)1 40 19 39 85
Suzanne DIMPRE, CCU-AAH
Contact
dr.dimpre@gmail.com
00 33 1 40 19 39 85

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion